版本:
中国

BRIEF-Xencor's lead drug candidate receives orphan drug designation from FDA

May 11 Xencor Inc

* Xencor's lead drug candidate, xmab5871, receives orphan drug designation from fda for treatment of igg4-related disease Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐